Mosley W H, Benenson A S, Barui R
Bull World Health Organ. 1968;38(3):335-46.
Controlled field trials of a highly antigenic cholera vaccine were held in Matlab Bazar in rural East Pakistan in 1963 and again in 1964. In July-September 1965, a serological survey for cholera antibodies was carried out on a random sample of the field-trial population. This survey revealed that it was possible to demonstrate the effect of a single injection of the cholera vaccine per head on the proportion of the population with detectable vibriocidal and agglutinating antibody 10 and 22 months after injection. More significantly, the reduction in cholera case rate caused by the vaccine could be correlated with the rise in vibriocidal antibody after vaccination, suggesting that the serological response to vaccine in man may be a useful measure of vaccine potency. The survey also indicated that in this endemic cholera area, with a high level of immunity in adults, a single injection of cholera vaccine was in fact a booster dose for the majority of the population. Thus, the results of cholera vaccine field trials in endemic areas cannot be directly extrapolated to predict the effects of the same vaccine in non-endemic areas.
1963年和1964年,在东巴基斯坦农村的马特拉巴扎尔对一种高抗原性霍乱疫苗进行了对照现场试验。1965年7月至9月,对现场试验人群的一个随机样本进行了霍乱抗体血清学调查。这项调查显示,在注射疫苗10个月和22个月后,有可能证明每人单次注射霍乱疫苗对可检测到杀弧菌和凝集抗体的人群比例的影响。更重要的是,疫苗导致的霍乱发病率降低与接种疫苗后杀弧菌抗体的升高相关,这表明人体对疫苗的血清学反应可能是衡量疫苗效力的一个有用指标。该调查还表明,在这个霍乱流行地区,成年人免疫力水平较高,实际上单次注射霍乱疫苗对大多数人群来说是一次加强剂量。因此,霍乱疫苗在流行地区的现场试验结果不能直接外推,以预测同一疫苗在非流行地区的效果。